| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. | Director | Common Stock | 6,157 | $15,761 | $2.56 | 12 Dec 2025 | Direct |
| Traws Pharma, Inc. | Director | Stock Option (right to purchase) | 24,629 | 12 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | 12 Dec 2025 | 2 | $0 | 4 | Director | 16 Dec 2025, 18:22 |
| TRAW | Traws Pharma, Inc. | 12 Oct 2025 | 1 | $0 | 4 | Director | 15 Oct 2025, 20:04 |
| TRAW | Traws Pharma, Inc. | 19 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 17:59 |
| TRAW | Onconova Therapeutics, Inc. | 10 Aug 2023 | 1 | $0 | 4 | Director | 14 Aug 2023, 18:47 |
| TRAW | Onconova Therapeutics, Inc. | 15 Dec 2022 | 1 | $0 | 4 | Director | 19 Dec 2022, 17:59 |
| TRAW | Onconova Therapeutics, Inc. | 15 Dec 2022 | 0 | $0 | 3 | Director | 19 Dec 2022, 17:52 |